Objects
Nielsen, Suzanne, Larance, Briony, Lintzeris, Nicholas, Black, Emma, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa. Wiley-Blackwell Publishing; 2013. Correlates of pain in an in-treatment sample of opioid-dependent people.
Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa. Elsevier; 2022. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.
Nielsen, Suzanne, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa, Demirkol, Apo, Muhleisen, Peter, Lintzeris, Nicholas. Wiley-Blackwell; 2016. Treating codeine dependence with buprenorphine: dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia.
Nielsen, Suzanne, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa, Demirkol, Apo, Muhleisen, Peter, Lintzeris, Nicholas. Wiley-Blackwell; 2015. Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series.
Larance, Briony, Bruno, Raimondo, Mattick, Richard P., Lintzeris, Nicholas, Degenhardt, Louise, Black, Emma, Brown, Amanda, Nielsen, Suzanne, Dunlop, Adrian, Holland, Rohan, Cohen, Milton. Elsevier; 2016. Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the Opioid-Related Behaviours In Treatment (ORBIT) scale.
Nielsen, Suzanne, Lintzeris, Nicholas, Dunlop, Adrian, Demirkol, Apo, Silsbury, Catherine, Phung, Nghi, Houseman, Jennie, Larance, Briony, Murnion, Bridin, Degenhardt, Louisa, Bruno, Raimondo, Haber, Paul, Johnson, Jennifer, Hardy, Mark, Ling, Stephen, Saddler, Craig. Wiley-Blackwell; 2018. Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence.
Murnion, Bridin Patricia, Rivas, Consuelo, Demirkol, Apo, Hayes, Vicky, Lintzeris, Nicholas, Nielsen, Suzanne. Oxford University Press; 2020. Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or gabapentin: a double-blind crossover pilot study.
Nielsen, Suzanne, Picco, Louisa, Farrell, Michael, Lintzeris, Nicholas, Le Foll, Bernard, Murnion, Bridin, Winters, Bryony, Matheson, Justin, Graham, Myfanwy, Campbell, Gabrielle, Parvaresh, Laila, Khor, Kok-Eng, Betz-Stablein, Brigid. Nature Publishing Group; 2022. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies.
Langford, Aili V., Bero, Lisa, Lin, Chung-Wei Christine, Blyth, Fiona M., Doctor, Jason N., Holliday, Simon, Jeon, Yun-Hee, Moullin, Joanna C., Murnion, Bridin, Nielsen, Suzanne, Penm, Jonathan, Reeve, Emily, Reid, Sharon, Wale, Janet, Osman, Rawa, Gnjidic, Danijela, Schneider, Carl R.. Elsevier; 2024. Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care.
Langford, Aili V., Lin, Christine C. W., Osman, Rawa, Penm, Jonathan, Reeve, Emily, Reid, Sharon, Wale, Janet, Schneider, Carl R., Gnjidic, Danijela, Bero, Lisa, Blyth, Fiona M., Doctor, Jason, Holliday, Simon, Jeon, Yun-Hee, Moullin, Joanna, Murnion, Bridin, Nielsen, Suzanne. John Wiley & Sons; 2023. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations.
Farrell, Michael, Shahbazi, Jeyran, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa, Chambers, Mark, Byrne, Marianne, Gholami, Jaleh, Zahra, Emma, Grebely, Jason, Lintzeris, Nicholas, Larance, Briony, Ali, Robert. Elsevier; 2024. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.